BHCM
NVRO

Brevan Howard Capital Management’s NEVRO CORP. NVRO Stock Holding History

Brevan Howard Capital Management’s Portfolio NVRO Stock Details NVRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-11,605
Closed -$168K – 1458
2024
Q1 		$168K Buy
+11,605
New +$192K ﹤0.01% 833

Other funds holding NVRO

ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Brevan Howard Capital Management's NVRO Position: Q2 2024 in Review

Brevan Howard Capital Management sold out of NEVRO CORP. (NVRO) in Q2 2024, closing a stake of 11,605 shares — an estimated $168K sold.

Brevan Howard Capital Management first reported a position in NVRO in Q1 2024 and held it in 1 quarter. The position peaked at $168K in Q1 2024. 152 funds tracked by Wall St. Rank hold NVRO as of Q2 2024.

  • Brevan Howard Capital Management reported no remaining NEVRO CORP. position as of Q2 2024 after selling out during the quarter.
  • Brevan Howard Capital Management sold 11,605 NEVRO CORP. shares in Q2 2024, an estimated $168K.
  • Brevan Howard Capital Management first reported a position in NEVRO CORP. in Q1 2024 and held it in 1 quarter.
  • Brevan Howard Capital Management's NEVRO CORP. position peaked at $168K in Q1 2024.
  • 152 funds tracked by Wall St. Rank held NEVRO CORP. as of Q2 2024.

Based on Brevan Howard Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.